KBC Group Portfolio holdings
AUM
$37B
1-Year Return
25.48%
This Quarter Return
+16.44%
1 Year Return
+25.48%
3 Year Return
+109.09%
5 Year Return
+189.42%
10 Year Return
+443.03%
AUM
$37B
AUM Growth
+$4.8B
(+15%)
Cap. Flow
+$1.41B
Cap. Flow
% of AUM
3.8%
Top 10 Holdings %
Top 10 Hldgs %
36.45%
Holding
1,898
New
21
Increased
352
Reduced
1,245
Closed
128
Top Buys
| 1 |
Microsoft
MSFT
|
$435M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$366M |
| 3 |
NVIDIA
NVDA
|
$318M |
| 4 |
Amazon
AMZN
|
$272M |
| 5 |
JPMorgan Chase
JPM
|
$268M |
Top Sells
| 1 |
IBM
IBM
|
$219M |
| 2 |
DFS
Discover Financial Services
DFS
|
$153M |
| 3 |
Comcast
CMCSA
|
$145M |
| 4 |
Coca-Cola
KO
|
$116M |
| 5 |
GoDaddy
GDDY
|
$103M |
Sector Composition
| 1 | Technology | 35.4% |
| 2 | Financials | 14.08% |
| 3 | Communication Services | 12.92% |
| 4 | Healthcare | 12.04% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Dyne Therapeutics
DYN
$2.02B
| $30K | ﹤0.01% |
3,135
| – | – |
|
1702
Immunovant
IMVT
$2.99B
| $29K | ﹤0.01% |
1,807
-1,735
| -49% | -$27.8K |
|
1703
Intuitive Machines
LUNR
$1B
| $26K | ﹤0.01% |
2,407
| – | – |
|
1704
Hillenbrand
HI
$1.85B
| $25K | ﹤0.01% |
1,259
-2,141
| -63% | -$42.5K |
|
1705
Novavax
NVAX
$1.28B
| $22K | ﹤0.01% |
3,517
-4,437
| -56% | -$27.8K |
|
1706
Sabre
SABR
$675M
| $21K | ﹤0.01% |
6,516
-13,764
| -68% | -$44.4K |
|
1707
CareDx
CDNA
$736M
| $20K | ﹤0.01% |
1,034
-2,136
| -67% | -$41.3K |
|
1708
Ardelyx
ARDX
$1.57B
| $19K | ﹤0.01% |
4,929
-8,777
| -64% | -$33.8K |
|
1709
Vera Therapeutics
VERA
$1.54B
| $17K | ﹤0.01% |
702
-1,775
| -72% | -$43K |
|
1710
Kirby Corp
KEX
$4.97B
| $15K | ﹤0.01% |
132
-181
| -58% | -$20.6K |
|
1711
Kennametal
KMT
$1.67B
| $10K | ﹤0.01% |
425
-2,862
| -87% | -$67.3K |
|
1712
Applied Optoelectronics
AAOI
$1.45B
| – | – |
-1,333
| Closed | -$20K |
|
|
AAT
1713
American Assets Trust
AAT
$1.26B
| – | – |
-3,217
| Closed | -$65K |
|
1714
Adient
ADNT
$2B
| – | – |
-5,402
| Closed | -$69K |
|
1715
Adaptive Biotechnologies
ADPT
$1.96B
| – | – |
-8,378
| Closed | -$62K |
|
1716
Agilon Health
AGL
$497M
| – | – |
-16,198
| Closed | -$70K |
|
|
AHH
1717
Armada Hoffler Properties
AHH
$581M
| – | – |
-4,934
| Closed | -$37K |
|
1718
AMN Healthcare
AMN
$799M
| – | – |
-2,478
| Closed | -$61K |
|
1719
Amphastar Pharmaceuticals
AMPH
$1.37B
| – | – |
-2,159
| Closed | -$63K |
|
1720
American Woodmark
AMWD
$997M
| – | – |
-858
| Closed | -$50K |
|
1721
ANI Pharmaceuticals
ANIP
$2.07B
| – | – |
-1,273
| Closed | -$85K |
|
1722
Artivion
AORT
$2.05B
| – | – |
-2,878
| Closed | -$71K |
|
1723
Apogee Enterprises
APOG
$939M
| – | – |
-1,282
| Closed | -$59K |
|
1724
Arlo Technologies
ARLO
$1.89B
| – | – |
-6,167
| Closed | -$61K |
|
1725
Arvinas
ARVN
$575M
| – | – |
-2,885
| Closed | -$20K |
|